Qube Research & Technologies (QRT)
CMPX icon

Qube Research & Technologies (QRT)’s Compass Therapeutics CMPX Stock Holding History

Qube Research & Technologies (QRT)’s Portfolio CMPX Stock Details CMPX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$8.08M Buy
3,687,489
+1,137,133
+45% +$3.36M 0.01% 1399
2026
Q1 		$13.5M Buy
2,550,356
+2,108,551
+477% +$12.2M 0.02% 1105
2025
Q4 		$2.37M Buy
+441,805
New +$2.04M ﹤0.01% 2185
2023
Q2 		– Sell
-162,624
Closed -$532K – 2467
2023
Q1 		$532K Buy
162,624
+99,629
+158% +$391K ﹤0.01% 1549
2022
Q4 		$317K Buy
+62,995
New +$251K ﹤0.01% 1636
2022
Q2 		– Sell
-52,842
Closed -$72K – 2573
2022
Q1 		$72K Buy
52,842
+23,789
+82% +$49.2K ﹤0.01% 2128
2021
Q4 		$92K Buy
+29,053
New +$96.3K ﹤0.01% 2154

Other funds holding CMPX

TCM
Tang Capital Management San Diego, California $2.2B AUM 156.35% 1-Year Est. Return
O
OrbiMed New York $5.4B AUM 163.13% 1-Year Est. Return
SCM
Suvretta Capital Management New York $5.47B AUM 131.34% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
ES
Enavate Sciences Menlo Park, California $345M AUM 134.64% 1-Year Est. Return
VC
Vivo Capital Palo Alto, California $1.1B AUM 799.93% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
PAI
Palo Alto Investors Palo Alto, California $724M AUM 96.91% 1-Year Est. Return
Millennium Management
Millennium Management New York $276B AUM 44.8% 1-Year Est. Return

Qube Research & Technologies (QRT)'s CMPX Position: Q2 2026 in Review

Qube Research & Technologies (QRT) increased its Compass Therapeutics (CMPX) stake by 45% in Q2 2026, buying an estimated $3.36M and bringing the position to 3,687,489 shares worth $8.08M. The position accounts for 0.01% of the portfolio, ranked #1399.

Qube Research & Technologies (QRT) first reported a position in CMPX in Q4 2021 and has held it in 7 quarters since. The position peaked at $13.5M in Q1 2026. 216 funds tracked by Wall St. Rank hold CMPX as of Q2 2026.

  • Qube Research & Technologies (QRT) held 3,687,489 shares of Compass Therapeutics worth $8.08M as of Q2 2026.
  • Qube Research & Technologies (QRT) bought 1,137,133 Compass Therapeutics shares in Q2 2026, an estimated $3.36M.
  • Compass Therapeutics made up 0.01% of Qube Research & Technologies (QRT)'s portfolio in Q2 2026, its #1399 holding.
  • Qube Research & Technologies (QRT) first reported a position in Compass Therapeutics in Q4 2021 and has held it in 7 quarters since.
  • Qube Research & Technologies (QRT)'s Compass Therapeutics position peaked at $13.5M in Q1 2026.
  • 216 funds tracked by Wall St. Rank held Compass Therapeutics as of Q2 2026.

Based on Qube Research & Technologies (QRT)'s 13F filing for Q2 2026, filed 14 Aug 2026.